NFE2L2 and viral infectious disease: In summary, our data demonstrate that CDDO-Me could inhibit RABV infection in a manner dependent on Nrf2 activation in N2a cells, indicating that treatment with this compound serves as a therapeutic strategy for inhibiting RABV and protecting neurons during viral infection.